别嘌醇对 ESWL 后肾结石患者 MDA、NO、KIM-1 尿液水平、RI 和肾弹性成像的影响
别嘌醇对体外冲击波碎石术后肾结石患者丙二醛、一氧化氮、肾损伤分子-1尿液水平、阻力指数和肾弹性成像的影响
研究概览
详细说明
符合标准的肾结石受试者由研究组对本研究进行详细说明,并签署知情同意书。 病史与体格检查、全血细胞计数、Bun、肌酐、尿酸、尿液分析以及人体测量(体重和身高)一起记录。 然后每个受试者得到一种干预药物,别嘌醇 300 毫克或安慰剂。 别嘌醇300mg研细装入明胶胶囊中。 安慰剂是使用同样被插入明胶胶囊中的乳酸糖制成的。 安慰剂胶囊的形状、颜色、质地和重量与药物别嘌醇相同。 别嘌醇胶囊和安慰剂由Sanglah医院药房生产。
使用置换块法将受试者随机分配到别嘌醇组或安慰剂组。 每个受试者在 ESWL 前一天、ESWL 前 2 小时和 ESWL 后一天服用一种类型的胶囊,该胶囊由 3 个含有 300 mg 别嘌醇或安慰剂的胶囊组成。
该研究是双盲的,研究人员、受试者、数据收集者、结果裁决者和数据分析师不知道治疗的类型。 药物在密封的信封中使用未公开的代码提供,该代码将在研究结束时被发现。
用于ESWL科目的准备;每个受试者输注 0.9% NaCl,每分钟 20 滴,昂丹司琼 8 mg i.v.,哌替啶推注 50 mg i.v.,然后滴注哌替啶 50 mg 和 ketorolac 30 mg,每分钟滴注 500 ml NaCl 0.9%,20 滴,每分钟 20 滴.
研究者使用使用电磁发电机的西门子 litostar vario 进行 ESWL。 给出的冲击波数量是每节2500-3000个冲击波。 给定的冲击波强度在最初的 200 次冲击波中为 2 J,随后在其余冲击波中为 3 至 3.5 J。 给定的冲击波频率为 60 次/分钟。
在 ESWL 前 1 小时,使用中分法无菌采集 10 ml 尿样,用于检查生物标志物 KIM-1、NO 和 MDA。 此外,在 ESWL 两小时后和 ESWL 一天后取 10 毫升尿样。 ESWL 后的考试时间从 ESWL 会话结束开始计算。
RI 检查和肾脏 SWV 弹性成像在 ESWL 前一小时进行,随后由同一位放射科专家在 ESWL 后两周和一个月进行。
受试者对药物的依从性是根据从整个给药过程中取出的胶囊数量来评估的。 如果服用的胶囊数量较少,则受试者将被排除在分析之外。 不良事件或药物副作用被定义为研究期间的意外事件,例如经历与手术相关的并发症或对别嘌醇过敏。 研究者在 ESWL 后每周对受试者进行评估,以评估耐受性和可能的副作用。
如有药物副作用或严重不良事件(SAE),第一时间向伦理委员会报告,自首次发现之日起不超过24小时,并尽快采取行动,直至一系列事件结束。 SAE在SAE表格上写得很详细,包括以下内容;首次发现的时间、事件的表现形式、事发前的情况、事件的处理情况和处理结果。
如果受试者出现过敏反应(皮肤发红、眼睛或嘴巴肿胀)和严重胃肠道紊乱(呕吐、腹泻)等副作用,则该受试者将被排除在分析之外。 如果受试者经历与 ESWL 程序相关的并发症,例如输尿管阻塞、疼痛(VAS > 5)或有感染迹象,也将被排除在分析之外。 根据时间表、电话联系或通过家访访问医院时,将对受试者进行评估。
干预数据的信封将在数据分析后打开,由独立团队见证,即桑拉医院药房和桑拉医院研究部。
研究类型
注册 (实际的)
阶段
- 第四阶段
联系人和位置
学习地点
-
-
Bali
-
Denpasar、Bali、印度尼西亚、80114
- Sanglah General Hospital
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
纳入标准:
- 符合ESWL标准的肾结石患者
- 年龄 18 至 59 岁
- 同意参加这项研究
排除标准:
- 糖尿病患者
- 高血压患者
- 患有慢性肾脏病 IV 期和 V 期的患者
- 尿路感染患者
- 肥胖患者
- 尿酸超过 9mg/dL 的患者
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:四人间
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:介入组
从 ESWL 前一天开始,口服别嘌醇 300 mg,共 3 天
|
从 ESWL 前一天开始,口服别嘌醇 300mg,共 3 天。
其他名称:
|
|
安慰剂比较:控制组
从 ESWL 前一天开始,口服安慰剂共 3 天
|
从 ESWL 前一天开始,口服安慰剂共 3 天。
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
氧化应激
大体时间:ESWL 后两小时
|
通过定量双抗体夹心直接 ELISA 测定尿液中丙二醛 (MDA)、一氧化氮 (NO) 和肾损伤分子-1 (KIM-1) 的水平
|
ESWL 后两小时
|
|
氧化应激
大体时间:ESWL 后 24 小时
|
通过定量双抗体夹心直接 ELISA 测定尿液中丙二醛 (MDA)、一氧化氮 (NO) 和肾损伤分子-1 (KIM-1) 的水平
|
ESWL 后 24 小时
|
|
肾血管和生物物理损伤
大体时间:ESWL 两周后
|
ESWL 下叶间动脉的阻力指数 (RI) 变化和同侧肾病灶区的弹性成像
|
ESWL 两周后
|
|
肾血管和生物物理损伤
大体时间:ESWL后一个月
|
ESWL 下叶间动脉的阻力指数 (RI) 变化和同侧肾病灶区的弹性成像
|
ESWL后一个月
|
合作者和调查者
调查人员
- 首席研究员:Kadek B Santosa, Urologist、Sanglah General Hospital
出版物和有用的链接
一般刊物
- Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006 Jun;17(6):1503-20. doi: 10.1681/ASN.2006010017. Epub 2006 May 17. No abstract available.
- Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005 Jun;67(6):2089-100. doi: 10.1111/j.1523-1755.2005.00365.x.
- Tublin ME, Bude RO, Platt JF. Review. The resistive index in renal Doppler sonography: where do we stand? AJR Am J Roentgenol. 2003 Apr;180(4):885-92. doi: 10.2214/ajr.180.4.1800885. No abstract available.
- Puddu P, Puddu GM, Cravero E, Vizioli L, Muscari A. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications. J Cardiol. 2012 May;59(3):235-42. doi: 10.1016/j.jjcc.2012.01.013. Epub 2012 Mar 6.
- Erol T, Tekin A, Katircibasi MT, Sezgin N, Bilgi M, Tekin G, Zumrutdal A, Sezgin AT, Muderrisoglu H. Efficacy of allopurinol pretreatment for prevention of contrast-induced nephropathy: a randomized controlled trial. Int J Cardiol. 2013 Aug 20;167(4):1396-9. doi: 10.1016/j.ijcard.2012.04.068. Epub 2012 May 8.
- Girardi G, Berman J, Redecha P, Spruce L, Thurman JM, Kraus D, Hollmann TJ, Casali P, Caroll MC, Wetsel RA, Lambris JD, Holers VM, Salmon JE. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest. 2003 Dec;112(11):1644-54. doi: 10.1172/JCI18817. Erratum In: J Clin Invest. 2004 Feb;113(4):646.
- Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002 Jul;62(1):237-44. doi: 10.1046/j.1523-1755.2002.00433.x.
- Fahmy N, Sener A, Sabbisetti V, Nott L, Lang RM, Welk BK, Mendez-Probst CE, MacPhee RA, VanEerdewijk S, Cadieux PA, Bonventre JV, Razvi H. Urinary expression of novel tissue markers of kidney injury after ureteroscopy, shockwave lithotripsy, and in normal healthy controls. J Endourol. 2013 Dec;27(12):1455-62. doi: 10.1089/end.2013.0188. Epub 2013 Nov 1.
- Waikar SS, Curhan GC, Wald R, McCarthy EP, Chertow GM. Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol. 2006 Apr;17(4):1143-50. doi: 10.1681/ASN.2005091017. Epub 2006 Feb 22.
- Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014 Jul 3;371(1):58-66. doi: 10.1056/NEJMra1214243. No abstract available.
- Acharya, C.R., Sharma, A.K., and Kantharia, N.D. 2015. Involvement of oxidative stress in patients of gout and antioxidant effect of allopurinol. International Journal of Medical Science and Public Health; 4(2): pp 168 -172
- Aksoy H, Aksoy Y, Turhan H, Keles S, Ziypak T, Ozbey I. The effect of shock wave lithotripsy on nitric oxide and malondialdehyde levels in plasma and urine samples. Cell Biochem Funct. 2007 Sep-Oct;25(5):533-6. doi: 10.1002/cbf.1349.
- Denic A, Mathew J, Lerman LO, Lieske JC, Larson JJ, Alexander MP, Poggio E, Glassock RJ, Rule AD. Single-Nephron Glomerular Filtration Rate in Healthy Adults. N Engl J Med. 2017 Jun 15;376(24):2349-2357. doi: 10.1056/NEJMoa1614329.
- Alirezaei, A., Argani, H., Asgharpour, M., Bahadorimonfared, A., and Bakhtiyari, M. 2017. An update on allopurinol and kidney failure; new trend for an old drug. J Renal Inj Prev; 6(4): pp 297-302
- Alessio HM. 2000. In: Handbook of oxidants and antioxidants in exercise. Hanninen O, Packy L, Sen CK, editors. Elsevier; Amsterdam; pp 115-128
- Asnita Arif, Nurlaily Idris, Bachtiar Murtala, Andi Alfian Z, Sri Asriyani, and Hasyim Kasim. 2019. The Correlation Between Renal Shear Wave Elastography with Estimated Glomerular FiltrationRate in Chronic Kidney Disease. Jurnal Kedokteran Brawijaya; 30(4): pp 287-292
- Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol. 2004 Mar 16;555(Pt 3):589-606. doi: 10.1113/jphysiol.2003.055913. Epub 2003 Dec 23.
- Bonventre JV. Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant. 2009 Nov;24(11):3265-8. doi: 10.1093/ndt/gfp010. Epub 2009 Mar 23. No abstract available.
- Bonventre JV. Primary proximal tubule injury leads to epithelial cell cycle arrest, fibrosis, vascular rarefaction, and glomerulosclerosis. Kidney Int Suppl (2011). 2014 Nov;4(1):39-44. doi: 10.1038/kisup.2014.8.
- Brian R, Matlaga, Amy E. Krambeck, and James E. Lingeman. 2016. Surgical management of Upper Urinary Tract Calculi. Campbell-Walsh urology. Philadelphia: Elsevier; pp 1260-1276
- Burne-Taney MJ, Ascon DB, Daniels F, Racusen L, Baldwin W, Rabb H. B cell deficiency confers protection from renal ischemia reperfusion injury. J Immunol. 2003 Sep 15;171(6):3210-5. doi: 10.4049/jimmunol.171.6.3210.
- Busti A.J. 2015. The Differences in the Mechanisms of Action Between Allopurineol and Febuxostat. Available at: http://www.ebmconsult.com/articles/allopurinol\ and febuxostat-zyloprim-uloric-uric-acid-gout-mechanism. Accesed 9th August 2016
- Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009 Jun;53(6):961-73. doi: 10.1053/j.ajkd.2008.11.034. Epub 2009 Apr 5.
- Dahlan, M. Sopiyudin. 2009. Besar Sampel dan Pengambilan Sampel, dalam Penelitian Kedokteran dan Kesehatan. Jakarta: Salemba Medika
- Clark DL, Connors BA, Evan AP, Willis LR, Handa RK, Gao S. Localization of renal oxidative stress and inflammatory response after lithotripsy. BJU Int. 2009 Jun;103(11):1562-8. doi: 10.1111/j.1464-410X.2008.08260.x. Epub 2009 Jan 20.
- Day RO, Graham GG, Hicks M, McLachlan AJ, Stocker SL, Williams KM. Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol. Clin Pharmacokinet. 2007;46(8):623-44. doi: 10.2165/00003088-200746080-00001.
- de Geus HR, Betjes MG, Bakker J. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clin Kidney J. 2012 Apr;5(2):102-108. doi: 10.1093/ckj/sfs008.
- Denise grotto, lucas santa maria, Juliana Valentini, clóvis paniz, and gabriela schmitt e solange cristina garcia. 2009. Importance of the Lipid peroxidation biomarkers and methodological aspects for malondialdehyde quantification. Quim. Nova; 32(1): pp 169-174
- De Rosa S, Antonelli M, Ronco C. Hypothermia and kidney: a focus on ischaemia-reperfusion injury. Nephrol Dial Transplant. 2017 Feb 1;32(2):241-247. doi: 10.1093/ndt/gfw038.
- Dinh QN, Drummond GR, Sobey CG, Chrissobolis S. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed Res Int. 2014;2014:406960. doi: 10.1155/2014/406960. Epub 2014 Jul 20.
- Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol. 2000 Dec;15(3-4):290-301. doi: 10.1007/s004670000461.
- Fegan JE, Husmann DA, Alexander ME, Feagins B, and Preminger GM. 2009. Preservation of renal architecture durineg extracorporeal shock wave lithotripsy. J Endourol/Endourol Soc; 5: pp 273-6
- Garg AX, Parikh CR. Yin and Yang: acute kidney injury and chronic kidney disease. J Am Soc Nephrol. 2009 Jan;20(1):8-10. doi: 10.1681/ASN.2008111197. Epub 2008 Dec 31. No abstract available.
- George J, Struthers AD. Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress. Vasc Health Risk Manag. 2009;5(1):265-72. doi: 10.2147/vhrm.s4265. Epub 2009 Apr 8.
- Graham S, Day RO, Wong H, McLachlan AJ, Bergendal L, Miners JO, Birkett DJ. Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects. Br J Clin Pharmacol. 1996 Apr;41(4):299-304. doi: 10.1046/j.1365-2125.1996.03116.x.
- Hatipoglu NK, Evliyaoglu O, Isik B, Bodakci MN, Bozkurt Y, Sancaktutar AA, Soylemez H, Atar M, Penbegul N, Yunce M, Daggulli M. Antioxidant signal and kidney injury molecule-1 levels in shockwave lithotripsy induced kidney injury. J Endourol. 2014 Feb;28(2):224-8. doi: 10.1089/end.2013.0535. Epub 2013 Nov 9.
- Hirschberg R. Wound healing in the kidney: complex interactions in renal interstitial fibrogenesis. J Am Soc Nephrol. 2005 Jan;16(1):9-11. doi: 10.1681/ASN.2004110901. Epub 2004 Dec 1. No abstract available.
- Hobarth K, Maier A, Hofbauer J, Marberger M. Color flow Doppler sonography for extracorporeal shock wave lithotripsy. J Urol. 1993 Dec;150(6):1768-70. doi: 10.1016/s0022-5347(17)35890-1.
- Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. 2003 Dec;112(12):1776-84. doi: 10.1172/JCI20530.
- Kira VM, Fagundes DJ, Bandeira CO, Kaufman O, Fagundes AT, Ortiz V. Effects of repeated extracorporeal shock wave on kidney apoptosis of normal and diabetic rat. Int Braz J Urol. 2008 Jan-Feb;34(1):91-6. doi: 10.1590/s1677-55382008000100013.
- Kostic D.a., Dimitrijevic D.S., Stojanovic G.S., Palic I.R., Dordevic A.S., and Ickovski J.D. 2015. Xanthine Oxidase: Isolation, Assays of Activity, and Inhibition. Journal of Chemistry; available at https://doi.org/10.1155/2015/294858
- Kou B, Ni J, Vatish M, Singer DR. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis. Microcirculation. 2008 Apr;15(3):251-67. doi: 10.1080/10739680701651495.
- Kurt S, Tokgoz O, Tokgoz H, Voyvoda N. Evaluation of effects of Extracorporeal Shock Wave Lithotripsy on renal vasculature with Doppler ultrasonography. Med Ultrason. 2013 Dec;15(4):273-7. doi: 10.11152/mu.2013.2066.154.sk2.
- Li B, Zhou W, Li P. Protective effects of nifedipine and allopurinol on high energy shock wave induced acute changes of renal function. J Urol. 1995 Mar;153(3 Pt 1):596-8.
- Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol. 2004 Jan;15(1):1-12. doi: 10.1097/01.asn.0000106015.29070.e7.
- Macias-Nunez JF, Revert M, Fiksen-Olsen M, Knox FG, Romero JC. Effect of allopurinol on the renovascular responses to adenosine. J Lab Clin Med. 1986 Jul;108(1):30-6.
- Margaret S. Pearle, and Yair Lotan. 2016. Urineary Lithiasis; Etiology, Epidemiology, and Pathogenesis. Campbell-Walsh urology. Philadelphia: Elsevier, pp.1363-1391
- McClintock DS, Santore MT, Lee VY, Brunelle J, Budinger GR, Zong WX, Thompson CB, Hay N, Chandel NS. Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death. Mol Cell Biol. 2002 Jan;22(1):94-104. doi: 10.1128/MCB.22.1.94-104.2002.
- McDonagh EM, Thorn CF, Callaghan JT, Altman RB, Klein TE. PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics. Pharmacogenet Genomics. 2014 Sep;24(9):464-76. doi: 10.1097/FPC.0000000000000058. No abstract available.
- Miller NL, Evan AP, Lingeman JE. Pathogenesis of renal calculi. Urol Clin North Am. 2007 Aug;34(3):295-313. doi: 10.1016/j.ucl.2007.05.007.
- Munver R, Delvecchio FC, Kuo RL, Brown SA, Zhong P, Preminger GM. In vivo assessment of free radical activity during shock wave lithotripsy using a microdialysis system: the renoprotective action of allopurinol. J Urol. 2002 Jan;167(1):327-34.
- Nakao T, Ushigome H, Nakamura T, Harada S, Koshino K, Suzuki T, Ito T, Nobori S, Yoshimura N. Evaluation of renal allograft fibrosis by transient elastography (Fibro Scan). Transplant Proc. 2015 Apr;47(3):640-3. doi: 10.1016/j.transproceed.2014.12.034.
- Mercimek MN, Ender O. Effect of urinary stone disease and its treatment on renal function. World J Nephrol. 2015 May 6;4(2):271-6. doi: 10.5527/wjn.v4.i2.271.
- Weimert NA, Tanke WF, Sims JJ. Allopurinol as a cardioprotectant during coronary artery bypass graft surgery. Ann Pharmacother. 2003 Nov;37(11):1708-11. doi: 10.1345/aph.1D023.
- Kwon O, Hong SM, Ramesh G. Diminished NO generation by injured endothelium and loss of macula densa nNOS may contribute to sustained acute kidney injury after ischemia-reperfusion. Am J Physiol Renal Physiol. 2009 Jan;296(1):F25-33. doi: 10.1152/ajprenal.90531.2008. Epub 2008 Oct 29.
- Ozkan F, Goya C, Yildiz S, Duymus M, Menzilcioglu SM, and Avcu S. 2016. Ultrasound elastography in kidney disease. In: Patel VB, Preedy VR (ed), Biomarkers in Kidney Disease, Biomarkers in Disease: Methods, Discoveries and Applications; pp 1052-1072
- Ozturk A, Grajo JR, Dhyani M, Anthony BW, Samir AE. Principles of ultrasound elastography. Abdom Radiol (NY). 2018 Apr;43(4):773-785. doi: 10.1007/s00261-018-1475-6.
- Platt JF. Duplex Doppler evaluation of native kidney dysfunction: obstructive and nonobstructive disease. AJR Am J Roentgenol. 1992 May;158(5):1035-42. doi: 10.2214/ajr.158.5.1566663.
- Pocock J. Stuart. 2013. Clinical Trials a Practical Approach. New York: Jon Wiley and Son-Brisbane-Toronto
- Pozniak, M., and Allan, P. 2014. Clinical doppler ultrasound (3rd ed). Philadelphia: Chucill-Livingstone Elsevier; pp 193-213
- Pries AR, Kuebler WM. Normal endothelium. Handb Exp Pharmacol. 2006;(176 Pt 1):1-40. doi: 10.1007/3-540-32967-6_1.
- Rosenblum ER, Gavaler JS, Van Thiel DH. Lipid peroxidation: a mechanism for alcohol-induced testicular injury. Free Radic Biol Med. 1989;7(5):569-77. doi: 10.1016/0891-5849(89)90034-8.
- Sagor MA, Tabassum N, Potol MA, Alam MA. Xanthine Oxidase Inhibitor, Allopurinol, Prevented Oxidative Stress, Fibrosis, and Myocardial Damage in Isoproterenol Induced Aged Rats. Oxid Med Cell Longev. 2015;2015:478039. doi: 10.1155/2015/478039. Epub 2015 Jun 7.
- Santoso dan Singgih. 2016. Statistik Parametrik Konsep dan Aplikasi dengan SPSS. Edisi Revisi.Jakarta: Media Komputindo (Gramedia).
- Shao X, Tian L, Xu W, Zhang Z, Wang C, Qi C, Ni Z, Mou S. Diagnostic value of urinary kidney injury molecule 1 for acute kidney injury: a meta-analysis. PLoS One. 2014 Jan 3;9(1):e84131. doi: 10.1371/journal.pone.0084131. eCollection 2014.
- Shaw CA, Taylor EL, Megson IL, Rossi AG. Nitric oxide and the resolution of inflammation: implications for atherosclerosis. Mem Inst Oswaldo Cruz. 2005 Mar;100 Suppl 1:67-71. doi: 10.1590/s0074-02762005000900012. Epub 2005 Jun 14.
- Singh H, Panta OB, Khanal U, Ghimire RK. Renal Cortical Elastography: Normal Values and Variations. J Med Ultrasound. 2017 Oct-Dec;25(4):215-220. doi: 10.1016/j.jmu.2017.04.003. Epub 2017 May 31.
- Singh, I. and Strandhoy, J W. 2012. Pathophysiology of Urineary Tract Obstruction. In: Wein, A.J. Kavoussi, L.R. Novick, A.C. Partin, A.W.Peters, C.A. Editors. Campbell-Walsh Urology, 10th Ed. Saunders. Esevier. Philadelphia
- Stamp LK, Day RO, Yun J. Allopurinol hypersensitivity: investigating the cause and minimizing the risk. Nat Rev Rheumatol. 2016 Apr;12(4):235-42. doi: 10.1038/nrrheum.2015.132. Epub 2015 Sep 29. Erratum In: Nat Rev Rheumatol. 2016 Apr;12(4):i.
- Thurston MM, Phillips BB, Bourg CA. Safety and efficacy of allopurinol in chronic kidney disease. Ann Pharmacother. 2013 Nov;47(11):1507-16. doi: 10.1177/1060028013504740. Epub 2013 Oct 9.
- Toprak O, Cirit M, Esi E, Postaci N, Yesil M, Bayata S. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease. Catheter Cardiovasc Interv. 2006 Feb;67(2):227-35. doi: 10.1002/ccd.20598.
- Vadas M. and Limaye v. 2005. The vascular endothelium: structure and function. In: Fitridge R. and Thompson M., editors. Mechanisms of Vascular Disease: A Textbook for Vascular Surgeons. Cambridge University Press: pp 1-10
- Waanders F, van Timmeren MM, Stegeman CA, Bakker SJ, van Goor H. Kidney injury molecule-1 in renal disease. J Pathol. 2010 Jan;220(1):7-16. doi: 10.1002/path.2642.
- Yalavarthy R, Edelstein CL. Therapeutic and predictive targets of AKI. Clin Nephrol. 2008 Dec;70(6):453-63. doi: 10.5414/cnp70453.
- Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med. 2010 May;16(5):535-43, 1p following 143. doi: 10.1038/nm.2144. Epub 2010 May 2.
- Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 2006 Jan;69(2):213-7. doi: 10.1038/sj.ki.5000054.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.